Observational Study of Baska Mask, a New Supraglottic Airway Device

March 23, 2012 updated by: John Laffey, University College Hospital Galway
The Baska mask is a new supraglottic airway device . The investigators would like to assess its performance in setting in which the current standard - LMA device - is being used.

Study Overview

Detailed Description

Our group has performed a number of studies on novel airway devices. In this study we would like to evaluate a new supraglottic airway named Baska mask. We would like to monitor certain parameters (time to and ease of insertion, failure rate, seal pressures, complications etc) as regarding the performance and safety profile of this device. This is a descriptive case series of patients undergoing airway management under general anaesthesia.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Galway, Ireland
        • Galway University Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Written informed Consent
  • No relevant drug allergies
  • Body-mass index (BMI) 20-35
  • Age 18-65
  • Non-urgent surgery of planned duration 0-2 hrs

Exclusion Criteria:

  • Inability of patient/parent to understand or consent for the trial
  • Non-English speakers
  • Neck pathology
  • Previous or anticipated problems with the upper airway or upper GI tract (reflux, hiatus hernia, oropharyngeal tumour, upper respiratory tract infection in the last 10 days etc)
  • BMI >35
  • Expected Difficult airway
  • Live Pregnancy
  • Increased risk for Gastric Aspiration

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Baska
use of a supraglottic airway device as a standard part of a general anaesthetic
Other Names:
  • Baska mask

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Device Placement Success rate
Time Frame: within 30 mins of anaesthesia commencement
within 30 mins of anaesthesia commencement
time to placement of device
Time Frame: within 30 mins of anaesthesia commencement
from the moment the device touched until successful ventilation achieved or device removed
within 30 mins of anaesthesia commencement

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
airway leak pressure of the device
Time Frame: within 30 mins of anaesthetic commencement
within 30 mins of anaesthetic commencement
user-rated ease of insertion of device
Time Frame: within 30 mins of anaestesia commencement
10cm visual analog score to be used
within 30 mins of anaestesia commencement
complication rates
Time Frame: From the moment general anaesthesia commenced up to 1 day postoperatively
complications specifically monitored will be desaturation episodes, laryngospasm, blood staining of the device, lip damage. We will record other complications related to the use of the device, including but not limited to loss of airway with need to manioulate mask/switch to alternative device, regurgitation, aspiration, teeth damage.
From the moment general anaesthesia commenced up to 1 day postoperatively
patient comfort indices
Time Frame: from the moment the patient awake up to 1 day postoperatively
Throat pain, dysphagia and dysphonia will be assessed. 10 point verbal rating scale will be used
from the moment the patient awake up to 1 day postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: John G Laffey, FFARCSI, National University of Ireland, Galway and Galway University Hospitals

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2011

Primary Completion (Actual)

December 1, 2011

Study Completion (Actual)

December 1, 2011

Study Registration Dates

First Submitted

December 18, 2011

First Submitted That Met QC Criteria

December 20, 2011

First Posted (Estimate)

December 21, 2011

Study Record Updates

Last Update Posted (Estimate)

March 26, 2012

Last Update Submitted That Met QC Criteria

March 23, 2012

Last Verified

March 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • C.A.621

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Performance and Safety of a New Supraglottic Airway Device

Clinical Trials on Placement and use of Baska mask

Subscribe